MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation

Title
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume 4, Issue 2, Pages 101-112
Publisher
American Association for Cancer Research (AACR)
Online
2015-11-25
DOI
10.1158/2326-6066.cir-15-0070-t

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation